These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6415747)

  • 21. Tolerance to fenfluramine anorexia: fact or fiction?
    Rowland NE; Carlton J
    Appetite; 1986; 7 Suppl():71-83. PubMed ID: 2427024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of depletion of brain serotonin by repeated fenfluramine on neurochemical and anorectic effects of acute fenfluramine.
    Kleven MS; Schuster CR; Seiden LS
    J Pharmacol Exp Ther; 1988 Sep; 246(3):822-8. PubMed ID: 2458447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on the mechanisms of tolerance to the anorectic effect of salbutamol in rats.
    Bendotti C; Borsini F; Samanin R
    Eur J Pharmacol; 1983 Sep; 92(3-4):237-42. PubMed ID: 6138263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the time course of the anorectic effect of fenfluramine and amphetamine with drug levels in blood.
    Blundell JE; Campbell DB; Lesham M; Tozer R
    J Pharm Pharmacol; 1975 Mar; 27(3):187-92. PubMed ID: 238002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tolerance and cross tolerance to the anorexigenic effect of appetite suppressants in rats.
    Opitz K
    Int J Obes; 1978; 2(1):59-68. PubMed ID: 711356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specificity of serotoninergic involvement in the decrease of food intake induced by quipazine in the rat.
    Samanin R; Bendotti C; Candelaresi G; Garattini S
    Life Sci; 1977 Nov; 21(9):1259-66. PubMed ID: 270605
    [No Abstract]   [Full Text] [Related]  

  • 27. Anorectic actions of the opiate antagonist naloxone.
    McCarthy PS; Dettmar PW; Lynn AG; Sanger DJ
    Neuropharmacology; 1981 Dec; 20(12B):1347-9. PubMed ID: 7322306
    [No Abstract]   [Full Text] [Related]  

  • 28. Possible involvement of endogenous opiates in the tolerance to the anorectic effect of fenfluramine.
    Groppetti A; Parenti M; Dellavedova L; Tirone F
    J Pharmacol Exp Ther; 1984 Feb; 228(2):446-53. PubMed ID: 6694120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulus generalization by fenfluramine in a quipazine-ketanserin drug discrimination is not dependent on indirect serotonin release.
    Smith RL; Gresch PJ; Barrett RJ; Sanders-Bush E
    Pharmacol Biochem Behav; 2002 May; 72(1-2):77-85. PubMed ID: 11900772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circling produced by serotonin and dopamine agonists in raphe lesioned rats: a serotonin model.
    Slater P
    Pharmacol Biochem Behav; 1980 Dec; 13(6):817-21. PubMed ID: 7193875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fenfluramine disrupts the behavioural satiety sequence in rats.
    Montgomery AM; Willner P
    Psychopharmacology (Berl); 1988; 94(3):397-401. PubMed ID: 3128817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Behavioural analysis of the anorectic effects of fluoxetine and fenfluramine.
    Willner P; McGuirk J; Phillips G; Muscat R
    Psychopharmacology (Berl); 1990; 102(2):273-7. PubMed ID: 2274610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Behavioral and biochemical correlates of chronic administration of quipazine.
    Valencia-Flores M; Campos-Sepulveda E; Galindo-Morales JA; Lujan M; Colotla VA
    Pharmacol Biochem Behav; 1990 Jun; 36(2):299-304. PubMed ID: 2356204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The appetite suppressant, d-fenfluramine, decreases self-stimulation at a feeding site in the lateral hypothalamus.
    McClelland RC; Sarfaty T; Hernandez L; Hoebel BG
    Pharmacol Biochem Behav; 1989 Feb; 32(2):411-4. PubMed ID: 2726999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences between the anorexic actions of amphetamine and fenfluramine--possible effects on hunger and satiety.
    Blundell JE; Latham CJ; Leshem MB
    J Pharm Pharmacol; 1976 Jun; 28(6):471-7. PubMed ID: 7642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anorectic effect of fenfluramine, cholecystokinin and neurotensin in genetically obese (ob/ob) mice.
    Bailey CJ; Flatt PR
    Comp Biochem Physiol A Comp Physiol; 1986; 84(3):451-4. PubMed ID: 2874924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the behavioral effects of para-chloroamphetamine, chlordimeform, quipazine, and intraventricular serotonin in the rat.
    Pfister WR; Noland V; Lowy MT; Nichols DE; Yim GK
    Commun Psychopharmacol; 1978; 2(4):287-95. PubMed ID: 729354
    [No Abstract]   [Full Text] [Related]  

  • 38. Dissociation of the anorexic effects of fenfluramine and amphetamine following intrahypothalamic injection.
    Blundell JE; Leshem MB
    Br J Pharmacol; 1973 Jan; 47(1):183-5. PubMed ID: 4717019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Substituted phenethylamines and anorexia.
    Duhault J; Beregi L; Roman F
    Prog Neuropsychopharmacol; 1980; 4(4-5):341-9. PubMed ID: 7220660
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of depletion of brain dopamine by 6-hydroxydopamine on tolerance to the anorexic effect of d-amphetamine and fenfluramine in rats.
    Heffner TG; Seiden LS
    J Pharmacol Exp Ther; 1979 Jan; 208(1):134-43. PubMed ID: 759608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.